Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 126,473 | -522 | 0 | 3,444 | 1,216 |
| Gross Profit | 126,473 | -522 | N/A | 3,444 | 1,216 |
| Operating Expenses | 76,949 | 70,046 | -4,422 | 62,551 | 64,541 |
| Operating Income | 49,524 | -70,568 | -1,731 | -59,107 | -63,325 |
| Interest Expense | 3,187 | 1,948 | 1,880 | 1,727 | 1,501 |
| Other Income | 215 | 1,342 | 1,391 | 832 | 91 |
| Pre-tax Income | 46,552 | -71,174 | -2,220 | -60,002 | -64,735 |
| Net Income Continuous | 46,552 | -71,174 | -2,220 | -60,002 | -64,735 |
| Net Income | $46,552 | $-71,174 | $-68,796 | $-60,002 | $-64,735 |
| EPS Basic Total Ops | 7.20 | -11.40 | -10.20 | -9.80 | -14.00 |
| EPS Basic Continuous Ops | 7.29 | -11.31 | 2.12 | -9.79 | -14.03 |
| EPS Diluted Total Ops | 7.20 | -11.40 | -10.20 | -9.80 | -14.00 |
| EPS Diluted Continuous Ops | 7.17 | -11.31 | 2.12 | -9.79 | -14.03 |
| EBITDA(a) | $51,152 | $-69,168 | $6,213 | $-57,006 | $-61,211 |